FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Genetically modified mice are described, including mice having a functional IgM gene and modified to have a deletion of a CH1 domain and a hinge region in a heavy chain constant domain that is not an IgM, e.g., in an IgG heavy chain constant domain. Genetically modified mice that make human variable/mouse constant chimeric heavy chain antibodies having only a heavy chain (antibodies that lack a light chain), fully mouse heavy chain antibodies, or fully human heavy chain antibodies are provided.
EFFECT: presented group of inventions can be applied in medicine.
63 cl, 13 dwg, 4 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS | 2019 |
|
RU2805212C2 |
MOUSE PRODUCING BINDING PROTEINS CONTAINING VL-DOMAINS | 2011 |
|
RU2612903C2 |
HUMANISED LIGHT CHAIN MICE | 2012 |
|
RU2664181C2 |
NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES | 2013 |
|
RU2664473C2 |
HUMANIZED RODENTS WHICH EXPRESS HEAVY CHAINS CONTAINING VDOMAINS | 2013 |
|
RU2770016C2 |
MICE THAT PRODUCE BINDING PROTEINS CONTAINING V DOMAINS | 2011 |
|
RU2750219C2 |
HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | 2013 |
|
RU2656155C2 |
HUMANISED UNIVERSAL LIGHT CHAIN MICE | 2012 |
|
RU2664232C2 |
MICE WITH HUMANIZED UNIVERSAL LIGHT CHAIN | 2012 |
|
RU2787781C2 |
COMMON LIGHT CHAIN MOUSE | 2013 |
|
RU2683514C2 |
Authors
Dates
2016-11-20—Published
2010-12-10—Filed